CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Clinical trial NCT02861300 · COMPLETED
Trial details
- NCT number
- NCT02861300
- Sponsor
- David Bajor, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-12
- Primary completion
- 2023-01-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.